A database for AI-generated molecular “fingerprints”
Since 2022, MSAID has been marketing a patented successor of the software whose prototype sparked the company’s founding. It streamlines the analysis of complex, large datasets. MSAID COO…

Since 2022, MSAID has been marketing a patented successor of the software whose prototype sparked the company’s founding. It streamlines the analysis of complex, large datasets. MSAID COO…